Medicare coverage of targeted disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) -- both under Medicare Advantage and in separate Part D plans -- is likely to leave many ...
President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut costs associated with prescription drugs.
A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.
More than 80% of patients with newly diagnosed rheumatoid arthritis, who were using bridging therapy, successfully tapered off prednisolone at 7 weeks, according to data published in the Annals of the ...
While rheumatoid arthritis (RA) is not commonly thought to affect the brain, research shows that many people with the condition have some level of cognitive impairment. “Brain fog is a pretty common ...
Dr. Reddy’s Laboratories (RDY) announced on Friday that the U.S. Food and Drug Administration has accepted for review its marketing application for a biosimilar targeting Orencia, a blockbuster ...
Sepsis and RA are two distinct, but related inflammatory conditions commonly driven by the body’s dysregulated, overactive immune responses and excessive cytokine/chemokine production. Sepsis, a ...
MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research have unveiled a novel drug discovery strategy that transforms a previously identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results